Yang YL, Xu B, Song YG, Zhang WD. Overexpression of c-fos in Helicobacter pylori-induced gastric precancerosis of Mongolian gerbil. World J Gastroenterol 2003; 9(3): 521-524
Corresponding Author of This Article
Dr. Yong-Li Yao, Institute of Gastrointestinal Diseases, Nanfang Hospital, First Military Medical University, Guang-zhou 510515, Guangdong Province, China. firstname.lastname@example.org
Article-Type of This Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastroenterol. Mar 15, 2003; 9(3): 521-524 Published online Mar 15, 2003. doi: 10.3748/wjg.v9.i3.521
Overexpression of c-fos in Helicobacter pylori-induced gastric precancerosis of Mongolian gerbil
Yong-Li Yang, Bo Xu, Yu-Gang Song, Wan-Dai Zhang
Yong-Li Yang, Yu-Gang Song, Wan-Dai Zhang, Institute of Gastrointestinal Diseases, Nanfang Hospital, First Military Medical University, Guangzhou 510515, Guangdong Province, China
Bo Xu, Department of Orthopedics, Nanfang Hospital, First Military Medical University, Guangzhou 510515, Guangdong Province, China
ORCID number: $[AuthorORCIDs]
Author contributions: All authors contributed equally to the work.
Correspondence to: Dr. Yong-Li Yao, Institute of Gastrointestinal Diseases, Nanfang Hospital, First Military Medical University, Guang-zhou 510515, Guangdong Province, China. email@example.com
Telephone: +86-20-85141547 Fax: +86-20-87208770
Received: September 26, 2001 Revised: October 23, 2001 Accepted: November 6, 2001 Published online: March 15, 2003
AIM: To explore dysregulation of c-fos in several human malignancies, and to further investigate the role of c-fos in Helicobacter pylori (H. pylori)-induced gastric precancerosis.
METHODS: Four-week-old male Mongolian gerbils were employed in the study. 0.5 mL 1 × 108 cfu·L-1 suspension of H. pylori NCTC 11637 in Brucella broth were inoculated orally into 20 Mongolian gerbils. Another 20 gerbils were inoculated with Brucella broth as controls. 10 of the infected gerbils and 10 of the non-infected control gerbils were sacrificed at 25 and 45 weeks after infection. The stomach of each gerbil was removed and opened for macroscopic observation. The expression of c-fos was analyzed by RT-PCR and immunohistochemical studies in H. pylori-induced gastric precancerosis of Mongolian gerbil. Half of each gastric antrum mucosa was dissected for RNA isolation and RT-PCR. β-actin was used as the housekeeping gene and amplified with c-fos as contrast. PCR products of c-fos were analyzed by gel image system and the level of c-fos was reflected with the ratio of c-fos/β-actin. The immunostaining for c-fos was conducted using monoclonal antibody of c-fos and the StreptAvidin-Biotin-enzyme Complex kit.
RESULTS: H. pylori was constantly found in all infected animals in this study. After infection of H. Pylori for 25 weeks, ulcers were observed in the antral and the body of stomach of 60% infected animals (6/10). Histological examination showed that all animals developed severe inflammation, especially in the area close to ulcers, and multifocal lymphoid follicles appeared in the lamina propria and submucosa. After infection of H. Pylori for 45 weeks, severe atrophic gastritis in all infected animals, intestinal metaplasia in 80% infected animals (8/10) and dysplasia in 60% infected animals (6/10) could be observed. C-fos mRNA levels were significantly higher after infection of H. pylori for 25 weeks (1.84 ± 0.79), and for 45 weeks (1.59 ± 0.37) than those in control-animals (0.74 ± 0.22, P < 0.01). C-fos mRNA levels were increased 2.5-fold by 25th week (P < 0.01) and 2.1-fold by 45th week (P < 0.01) in precancerosis induced by H. pylori, when compared with normal gastric epithelium of Mongolian gerbil. Immunohistochemical staining revealed exclusive nuclear staining of c-fos. Furthermore, there was a sequential increase in c-fos positive cells from normal epithelium to precancerosis.
CONCLUSION: The study suggested that overexpression of c-fos occurs relatively early in gastric tumorigenesis in this precancerosis model induced by H. pylori.
Key Words: $[Keywords]
Citation: Yang YL, Xu B, Song YG, Zhang WD. Overexpression of c-fos in Helicobacter pylori-induced gastric precancerosis of Mongolian gerbil. World J Gastroenterol 2003; 9(3): 521-524
H. pylori, a gram-negative spiral bacterium first isolated in 1982 from a patient with chronic active gastritis, is responsible for a large portion of chronic gastritis and nearly all duodental ulcers, most gastric ulcers, and probably an increased risk of gastric adenocarcinoma[1-9]. More than 50% of the adult population are infected with H. pylori in developing countries as well as in developed countries. Gastric cancer is a major health problem and remains the second most common cancer in the world. Although epidemiological studies have indicated that H. pylori infection plays a crucial role in human gastric carcinogenesis[12-25], there is no direct proof that H. pylori is actually associated with gastric carcinogenesis. The purpose of this study was to elucidate the relationship between H. pylori infection and gastric carcinogenesis by using an animal model of long-term H. pylori infection, and to explore the role played by c-fos in gastric tumorigenesis.
MATERIALS AND METHODS
Four-week-old specific pathogen-free male Mongolian gerbils weighing 20 ± 5 g were employed in this study. They were housed in individual metabolic cages in a temperature conditioned room 23 ± 2 °C with a 12 h light-dark cycle, allowed to access to standard rat chow (provided by Experimental Animal Center, First Military Medical University) and water ad labium, and acclimatized to the surrounding for 7 days prior to the experiments. H. pylori (NCTC 11637) was obtained from American Type Culture Collection and cultured on Brucella agar plates containing 70 mL·L-1 goat blood in a microaerobic condition (volume fraction, N2: 85%, O2: 5%, CO2: 10%, in aerobic globe box) at 37 °C for 3 days. The strain was identified by morphology, Gram’s stain, urease production and so on.
0.5 mL 1 × 108 cfu·L-1 suspension of H. pylori NCTC 11637 in Brucella broth were inoculated orally into 20 Mongolian gerbils for 14 days continuously which had been fasted overnight. Another 20 gerbils were inoculated with Brucella broth as controls. 10 of the infected gerbils and 10 of the non-infected control gerbils were sacrificed after infection for 25 and 45 weeks, respectively. The stomach of each animal was removed and opened for macroscopic observation. Half of each gastric antrum mucosa were dissected for RNA isolation. The rest of the stomach samples were used for histological examination, which were fixed with neutral-buffered 100 mL·L-1 formalin and processed by standard methods that embedded in paraffin, sectioned and attained with haematoxylin for analyzing histological changes, Giemsa stain for detecting for H. pylori and Alcian blue (AB)/PAS stain for examining intestinal metaplasia.
RNA isolation and RT-PCR analysiss
Using Tripure isolation reagent (Boehringer Mannheim, Germany), total cellular RNA was isolated from previously frozen tissues according to the manufacturer’s instruction. All RNA samples were analyzed for integrity of 18s and 28s rRNA by ethidium bromide staining of 0.5 μg RNA resolved by electrophoresis on 12 g·L-1 agarose-formaldehyde gels. RT-PCR analysis was performed as follows. RNA was incubated at 60 °C for 10 min and chilled to 4 °C immediately before being reverse transcribed. 1 μg of total RNA was reversely transcripted using antisense primers in a volume of 20 μL for 40 min at 50 °C, containing 200 U MMLV reverse transcriptase, 1×buffer RT, 1 MU·L-1 Rnasin, 0.5 mmol·L-1 dNTPs of dATP, dGTP, dCTP and dTTP and each antisense primers including c-fos and β-actin at 0.2 μmol·L-1. The samples were heated to 99 °C for 5 min to terminate the reverse transcription reaction. By using a Perkin-Elmer DNA Thermocycler 4800 (Perkin-Elmer, Norwalk, CT), 5 μL cDNA mixture obtained from the reverse transcription reaction was then amplified for c-fos and β-actin. β-actin was used as the housekeeping gene and amplified with c-fos as control. The amplification reaction mixture consisted of 10 × buffer 5 μL, 0.2 mmol·L-1 dNTPs of dATP, dGTP, dCTP and dTTP, 2.5 U Taq DNA polymerase, and sense and antisense primers at 0.2 μmol·L-1 in a final volume of 50 μL. The reaction mixture was first heated at 94 °C for 2 min and amplification was carried out for 29 cycles at 94 °C for 0.5 min, 58 °C for 1 min, 70 °C for 1.5 min, followed by an incubation for 7 min at 70 °C. The amplification cycles was previously determined to keep amplification in the linear range to avoid the “plateau effect” associated with increased PCR cycles. The PCR primers were as following: c-fos, sense 5’-CACGACCATGATGTTCTCGG-3’ and antisense 5’-AGTAGATTGGCAATCTCGGT-3’; β-actin, sense 5’-CCAAGGCCAACCGCGAGAAGATGAC-3’ and antisense 5’-AGGGTACATGGTGGTGCCGCCAGAC-3’. PCR products of c-fos and β-actin had 348 bp and 587 bp, respectively. PCR products were run on a 15 g·L-1 agarose gel in 0.5×TBE buffer and then analyzed by gel image analysis system. The level of c-fos was reflected with the ratio of c-fos/β-actin.
Four micrometers paraffin-embedded tissue sections were deparaffinized and rehydrated. Endogenous peroxidase activity was ablated with 10 mL·L-1 hydrogen peroxide in methanol. The immunostaining for c-fos was conducted using the StreptAvidin-Biotin-enzyme Complex kit (Boster, Wuhan). Immunostaining by replacing primary antibody with PBS was also conducted as a negative control. The staining was evaluated semiquantitatively on the basis of the percentage of positive cells, and classified as follows: diffusely positive (+++) when positive cells accounted for more than 70% of the total cells, partially positive (++) when positive cells were 35%-70%, partially positive (+) when positive cells accounted for 5%-35%, and negative (-) when positive cells accounted for less than 5%.
Experimental results were analyzed with Chi-square Tests and K-Related Samples Test by SPSS software. Statistical significance was determined at P < 0.05.
H. pylori was detected in gastric antrum and gastric body of all infected animals in this study, and more in gastric antrum than that in gastric body. After infection of H. Pylori for 25 weeks, ulcers were observed in the gastric antrum and gastric body in 60% infected animals (6/10). Histological examination showed that all infected animals developed severe inflammation, especially in the area close to ulcers; multifocal lymphoid follicles appeared in the lamina propria and submucosa; and there were mild atrophic gastritis in all infected animals. After infection of H. Pylori for 45 weeks, severe atrophic gastritis in all infected animals, intestinal metaplasia in 80% infected animals (8/10) and dysplasia in 60% infected animals (6/10) could be observed. Those metaplastic glands appeared more atypical than the surrounding nonmetaplastic and hyperplastic glands. Severe atrophic gastritis, intestinal metaplasia and dysplasia were gastric precancerosis. In the uninfected animals, there were no significant changes throughout the study.
Analysis of c-fos mRNA expression
There was c-fos mRNA expression in gastric antrum mucosa of control-animals. C-fos mRNA levels were significantly higher after infection of H. pylori for 25 weeks (1.84 ± 0.79), and for 45 weeks (1.59 ± 0.37) than that in control-animals (0.74 ± 0.22, P < 0.01); C-fos mRNA levels were increased 2.5-fold in 25 weeks (P < 0.01) and 2.1-fold in 45 weeks (P < 0.01) in precancerosis induced by H. pylori, when compared with control gastric epithelium of Mongolian gerbil (Figure 1, Figure 2, Figure 3, Figure 4).
Figure 1 RT-PCR products.
Lane 1 PCR marker; Lane 2 c-fos; Lane 3 β-actin.
Figure 2 RT-PCR analysis of c-fos mRNA levels using β-actin as internal control.
Total RNA was first reverse transcripted into cDNA and then amplified by PCR in control.
Figure 3 RT-PCR analysis of c-fos mRNA levels using β-actin as internal control after H.
pylori infection for 25 weeks.
Figure 4 RT-PCR analysis of c-fos mRNA levels using β-actin as internal control after H.
pylori infection for 45 weeks.
Immunohistochemical analysis of c-fos protein expression
Immunohistochemical analysis was performed to examine whether increased c-fos mRNA expression were accompanied by increased expression of c-fos protein. C-fos protein expression lied in nuclei (Figure 5). C-fos protein expression was evaluated significantly (P < 0.01) in precancerosis induced by H. pylori for 45 weeks, when compared with control gastric epithelium of Mongolian gerbil (Table 1).
Table 1 Expression of c-fos by Immunohistochemical staining.
Figure 5 Expression of c-fos after H.
pylori infection for 25 weeks, immunohistochemistry staining (×400).
H. pylori infection is now known as a major cause of acute and chronic active gastritis, peptic ulcer disease and atrophic gastritis and is also considered as a risk factor in the incidence of gastric adenocarcinoma and mucosa-associated lymphoma[1-8]. Chronic colonization of the human stomach by the gram-negative spiral bacterium H. pylori is associated with the development of cancer in the distal portion of the stomach. Although there is no direct proof that H. pylori is actually associated with gastric carcinogenesis, epidemiological studies have indicated that H. pylori infection plays an important role in human gastric carcinogenesis. Because of this strong epidemiological association, H. pylori is classified as a definite carcinogen (group I) by the International Agency for Research on Cancer (IRAC), a branch of the World Health Organization (WHO). Many animals infected with human H. pylori have already been studied to determine the pathogenetic background, but none of the models studied mimics human H. pylori infection and subsequent pathology. Recently, two exprements were conducted in Japan that demonstrated that chronic H. pylori-infection models of Mongolian gerbils would develope gastric carcinoma. These results will be extremely helpful to elucidate the mechanism of gastric carcinogenesis due to H. pylori infection[9-26]. Apoptosis, a programmed cell death, was ignored, just like H. pylori, only to reappear recently. However, the number of current publications dealing with apoptosis of H. pylori has increased exponentially. Although gastric epithelial apoptosis is a programmed physiological event in the superficial aspect of the mucosa and is important for healthy cell turnover, H. pylori infection reportedly promotes such a cell death sequence[27,28]. Because apoptosis regulates the cycle of cell turnover in balance with proliferation, dysregulation of apoptosis or proliferation evoked by H. pylori colonization would be linked to the gastric carcinogenesis[29-31].
C-fos is an immediate early response gene, and c-fos protein is an important transcription-factor of nuclei[32-39]. Oncogene c-fos is also a kind of effect protein of the karyomitosis signal, which can trigger and regulate the transcription of the genes related with proliferation. Besides, c-fos can also regulate its own gene expression with a positive feedback and promote the mitosis and proliferation of the cells. Because c-fos can regulate cell proliferation and cell apoptosis, its abnormal expression might induce cell turnover and carcinogenesis[40-46]. Previous studies have showed that the expression of oncogene c-fos is closely related to cellular multiplication and differentiation. The amplification and over-expression of c-fos gene are associated with malignancy and tumorigenecity of cells. Recently, some studies suggested that oncogene c-fos was amplified in the primary tumor DNA[47-49]. Shirin et al tested the hypothess that H. pylori might inhibit cell growth and cell cycle progression by inhibiting signaling pathways that mediate the transactivation of the serum-response element in the c-fos promoter.
In this study, mRNA level of c-fos was measured by quantitative RT-PCR analysis in Mongolian gerbil gastric antrum mucosa to explore dysregulation of c-fos in malignancies and to further investigate the role of c-fos in H. pylori-induced gastric precancerosis. In addition, the expression and localization of its protein product was analyzed by immunohistochemical staining. C-fos mRNA levels were significantly increased in precancerosis induced by H. pylori, when compared with normal gastric epithelium of Mongolian gerbil. Immunohistochemical staining revealed exclusive nuclear staining of c-fos. Furthermore, there was a sequential increase in c-fos positive cells from normal epithelium to precancerosis. This study indicates that the expression of c-fos mRNA and protein is increased from normal epithelium to precancerosis. The dysregulation of c-fos expression occurre relatively early in gastric tumorigenesis in this model and may participate in tumor progression. These findings suggeste that H. pylori- induced gastric precancerosis is associated with dysregulation of gastric epithelial cell cycle. Further studies are needed to delineate the mechanism of those alterations.
Edited by Xu XQ
Tabata H, Fuchigami T, Kobayashi H, Sakai Y, Nakanishi M, Tomioka K, Nakamura S, Fujishima M. Helicobacter pylori and mucosal atrophy in patients with gastric cancer: a special study regarding the methods for detecting Helicobacter pylori.Dig Dis Sci. 1999;44:2027-2034.
Meining AG, Bayerdörffer E, Stolte M. Helicobacter pylori gastritis of the gastric cancer phenotype in relatives of gastric carcinoma patients.Eur J Gastroenterol Hepatol. 1999;11:717-720.
Yamaoka Y, Kodama T, Kashima K, Graham DY. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.J Clin Pathol. 1999;52:215-218.
Danesh J. Helicobacter pylori infection and gastric cancer: systematic review of the epidemiological studies.Aliment Pharmacol Ther. 1999;13:851-856.
Harris RA, Owens DK, Witherell H, Parsonnet J. Helicobacter pylori and gastric cancer: what are the benefits of screening only for the CagA phenotype of H. pylori.Helicobacter. 1999;4:69-76.
Hansen S, Melby KK, Aase S, Jellum E, Vollset SE. Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. A nested case-control study.Scand J Gastroenterol. 1999;34:353-360.
Kuipers EJ. Review article: exploring the link between Helicobacter pylori and gastric cancer.Aliment Pharmacol Ther. 1999;13 Suppl 1:3-11.
Alexander GA, Brawley OW. Association of Helicobacter pylori infection with gastric cancer.Mil Med. 2000;165:21-27.
Zhuang XQ, Lin SR. Study on the relationship between Helicobacter pylori and gastric cancer.Shijie Huaren Xiaohua Zazhi. 2000;9:206-207.
Vandenplas Y. Helicobacter pylori infection.World J Gastroenterol. 2000;6:20-31.
Pan KF, Liu WD, Ma JL, Zhou T, Zhang L, Chang YS, You WC. Infection of Helicobacter pylori in children and mode of transmis-sion in a high-risk area of gastric cancer.Shijie Huaren Xiaohua Zazhi. 1998;6:42-44.
Zhang L, Jiang J, Pan KF, Liu WD, Ma JL, Zhou T, Perez GT, Blaser MJ, Chang YS, You WC. Infection of Helicobacter pylori with cag A strain in a high-risk area of gastric cancer.Shijie Huaren Xiaohua Zazhi. 1998;6:40-41.
Zhuang XQ, Lin SR. Study on Helicobacter pylori infection in gas-tric cancer and precancerosis.Shijie Huaren Xiaohua Zazhi. 2000;8:710-711.
Hu PJ. Helicobacter pylori and gastric cancer.Shijie Huaren Xiaohua Zazhi. 1999;7:1-2.
Huang XQ. Helicobacter pylori infection and gastrointestinal hormones: a review.World J Gastroenterol. 2000;6:783-788.
Wang XH, Zhang WD, Zhang YL, Zeng JZ, Sun Y. Relationship between Hp infection and oncogene and tumor suppressor gene expression in gastric cancer and precancerosis.Shijie Huaren Xiaohua Zazhi. 1998;6:516-518.
Ye GA, Zhang WD, Liu LM, Shi L, Xu ZM, Chen Y, Zhou DY. Hp vac A gene and chronic gastritis.Shijie Huaren Xiaohua Zazhi. 2001;9:593-594.
Quan J, Fan XG. Experimental studies on Helicobacter pylori and gastric cancer.Shijie Huaren Xiaohua Zazhi. 1999;7:1068-1069.
Lu SY, Pan XZ, Peng XW, Shi ZL, Lin L, Chen MH. Effect of Hp infection on gastric epithelial cell kinetics in stomach diseases.Shijie Huaren Xiaohua Zazhi. 2000;8:386-388.
Harry XH. Association between Helicobacter pylori and gastric cancer: current knowledge and future research.World J Gastroenterol. 1998;4:93-96.
Zu Y, Shu J, Yang CM, Zhong ZF, Dai HY, Wang X, Qin GM. Study on Helicobacter pylori infection and risk of gastric cancer.Shijie Huaren Xiaohua Zazhi. 1998;6:367-368.
Cai L, Yu SZ, Zhang ZF. Helicobacter pylori infection and risk of gastric cancer in Changle County,Fujian Province,China.World J Gastroenterol. 2000;6:374-376.
Shimizu M, Nikaido T, Toki T, Shiozawa T, Fujii S. Clear cell carcinoma has an expression pattern of cell cycle regulatory molecules that is unique among ovarian adenocarcinomas.Cancer. 1999;85:669-677.
Shirin H, Sordillo EM, Oh SH, Yamamoto H, Delohery T, Weinstein IB, Moss SF. Helicobacter pylori inhibits the G1 to S transition in AGS gastric epithelial cells.Cancer Res. 1999;59:2277-2281.
Gao H, Wang JY, Shen XZ, Liu JJ. Effect of Helicobacter pylori infection on gastric epithelial cell proliferation.World J Gastroenterol. 2000;6:442-444.
Suzuki H, Ishii H. Role of apoptosis in Helicobacter pylori-associated gastric mucosal injury.J Gastroenterol Hepatol. 2000;15 Suppl:D46-D54.
Zhuang XQ, Lin SR. Research of Helicobacter pylori infection in precancerous gastric lesions.World J Gastroenterol. 2000;6:428-429.
Gu JZ, Hou TW, Wang XX. Study on precancerous gastric le-sions induced by Helicobacter pylori.Shijie Huaren Xiaohua Zazhi. 2001;9:111.
Tischmeyer W, Grimm R. Activation of immediate early genes and memory formation.Cell Mol Life Sci. 1999;55:564-574.
Lennartsson J, Blume-Jensen P, Hermanson M, Pontén E, Carlberg M, Rönnstrand L. Phosphorylation of Shc by Src family kinases is necessary for stem cell factor receptor/c-kit mediated activation of the Ras/MAP kinase pathway and c-fos induction.Oncogene. 1999;18:5546-5553.
Trauth JA, Seidler FJ, McCook EC, Slotkin TA. Persistent c-fos induction by nicotine in developing rat brain regions: interaction with hypoxia.Pediatr Res. 1999;45:38-45.
Duan R, Porter W, Samudio I, Vyhlidal C, Kladde M, Safe S. Transcriptional activation of c-fos protooncogene by 17beta-estradiol: mechanism of aryl hydrocarbon receptor-mediated inhibition.Mol Endocrinol. 1999;13:1511-1521.
Morrissey JJ, Raney S, Heasley E, Rathinavelu P, Dauphinee M, Fallon JH. IRIDIUM exposure increases c-fos expression in the mouse brain only at levels which likely result in tissue heating.Neuroscience. 1999;92:1539-1546.
Hasebe T, Imoto S, Sasaki S, Tsubono Y, Mukai K. Proliferative activity and tumor angiogenesis is closely correlated to stromal cellularity of fibroadenoma: proposal fibroadenoma, cellular variant.Pathol Int. 1999;49:435-443.
Whong WZ, Gao HG, Zhou G, Ong T. Genetic alterations of cancer-related genes in glass fiber-induced transformed cells.J Toxicol Environ Health A. 1999;56:397-404.
Chen W, Dong Z, Valcic S, Timmermann BN, Bowden GT. Inhibition of ultraviolet B--induced c-fos gene expression and p38 mitogen-activated protein kinase activation by (-)-epigallocatechin gallate in a human keratinocyte cell line.Mol Carcinog. 1999;24:79-84.
Aigner A, Juhl H, Malerczyk C, Tkybusch A, Benz CC, Czubayko F. Expression of a truncated 100 kDa HER2 splice variant acts as an endogenous inhibitor of tumour cell proliferation.Oncogene. 2001;20:2101-2111.
Mitsuno Y, Yoshida H, Maeda S, Ogura K, Hirata Y, Kawabe T, Shiratori Y, Omata M. Helicobacter pylori induced transactivation of SRE and AP-1 through the ERK signalling pathway in gastric cancer cells.Gut. 2001;49:18-22.
He SW, Shen KQ, He YJ, Xie B, Zhao YM. Regulatory effect and mechanism of gastrin and its antagonists on colorectal carcinoma.World J Gastroenterol. 1999;5:408-416.
Yuan SL, Huang RM, Wang XJ, Song Y, Huang GQ. Reversing effect of Tanshinone on malignant phenotypes of human hepatocarcinoma cell line.World J Gastroenterol. 1998;4:317-319.
YH , Hu DR, Nie QH, Liu GD, Tan ZX. Study on activation and c-fos, c-jun expression of in vitro cultured human hepatic stellate cells.Shijie Huaren Xiaohua Zazhi. 2000;8:299-301.
Jiang LX, Fu XB, Sun TZ, Yang YH, Gu XM. Relationship be-tween oncogene c-jun activation and fibrobl.Shijie Huaren Xiaohua Zazhi. 1999;7:498-500.
Chen BW, Wang HT, Liu ZX, Jia BQ, Ma QJ. Effect of exogenous EGF on proto-oncogene expression in experimental gastric ulcers.Shijie Huaren Xiaohua Zazhi. 1999;7:504-506.
Chai Y, Chipitsyna G, Cui J, Liao B, Liu S, Aysola K, Yezdani M, Reddy ES, Rao VN. c-Fos oncogene regulator Elk-1 interacts with BRCA1 splice variants BRCA1a/1b and enhances BRCA1a/1b-mediated growth suppression in breast cancer cells.Oncogene. 2001;20:1357-1367.
Ma KS, Zhang FS, He ZP, Wanf SG, Zhong JH. Effect of CCK on cell apoptosis of bile duct neoplasms.Shijie Huaren Xiaohua Zazhi. 2000;8:1312-1313.
Salmi A, Carpén O, Rutanen E. The association between c-fos and c-jun expression and estrogen and progesterone receptors is lost in human endometrial cancer.Tumour Biol. 1999;20:202-211.